Quantcast

Latest CD4 Stories

2010-10-31 00:13:18

The CD4 Initiative at Imperial College, London, funded by Bill and Melinda Gates Foundation grants, is nearing a major breakthrough in HIV/AIDS care by developing a simple, inexpensive CD4 point-of-care test specifically designed for resource-poor settings. ImmunoSite Technologies has been developing QA materials for the innovative, disposable test kit. Fort Lauderdale, FL (PRWEB) October 30, 2010 Since early 2007, researchers from ImmunoSite Technologies (IST) have been working with a...

2010-10-08 02:22:15

In a technical tour de force, structural biologists funded by the National Institutes of Health have determined the three-dimensional structure of a molecule involved in HIV infection and in many forms of cancer. The high-resolution structure sheds light on how the molecule functions and could point to ways to control its activity, potentially locking out HIV and stalling cancer's spread. The molecule, CXCR4, is part of a large family of proteins called G-protein coupled receptors (GPCRs)....

2010-07-20 08:30:00

VIENNA and NEW YORK, July 20 /PRNewswire/ -- The Abzyme Research Foundation announces today that Dr. Sudhir Paul, a scientist at University of Texas Houston Medical School, has identified an important immunological deficiency in HIV-infected patients and has created a promising HIV vaccine candidate that rectifies the deficiency. The discoveries were presented on July 19th and 20th, 2010 at the XVII International AIDS Society Conference in Vienna, Austria. The HIV vaccine candidate has...

ab0e41698b43175704ac75b754c56fb6
2010-07-18 09:41:53

Microfluidic device uses antibodies to 'capture' white blood cells called T cells affected by HIV UC Davis biomedical engineer Prof. Alexander Revzin has developed a "lab on a chip" device for HIV testing. Revzin's microfluidic device uses antibodies to "capture" white blood cells called T cells that are affected by HIV. In addition to physically binding these cells the test detects the types and levels of inflammatory proteins (cytokines) released by the cells. Revzin's team collaborated...

6d4febf7b1797690e38c8f5295d01742
2010-07-09 10:53:44

Discovery to advance HIV vaccine design, antibody therapy for other diseases Scientists have discovered two potent human antibodies that can stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory, and have demonstrated how one of these disease-fighting proteins accomplishes this feat. According to the scientists, these antibodies could be used to design improved HIV vaccines, or could be further developed to prevent or treat HIV infection. Moreover,...

2010-07-06 06:00:00

RICHMOND, Calif., July 6 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the publication of data demonstrating the preclinical efficacy of a human stem cell therapy for human immunodeficiency virus (HIV) based on its proprietary zinc finger DNA-binding protein nuclease (ZFN) technology. The ZFN approach enables the permanent disruption of the CCR5 gene, which encodes an important receptor for HIV infection, in all the cell types comprising the immune system...

2010-05-14 12:52:12

HIV disease tends to progress at a faster rate in infected individuals who consume two or more alcoholic drinks a day, according to an important new paper in AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc. The article is available free online. The article, entitled "Alcohol Use Accelerates HIV Disease Progression," clearly demonstrates that frequent alcohol use, defined as two or more drinks daily, is associated with declining CD4+ cell counts...

2010-05-06 10:00:00

MELBOURNE, Australia, May 6 /PRNewswire/ -- The use of rapid point-of-care diagnostic tests for the measurement of CD4 T-cells, a marker of the immune system will be an important factor in improving the lives of people living with HIV and AIDS especially in developing and resource-poor countries. Speaking on global diagnostics at the Bio2010 International Convention in Chicago, Burnet Institute's Associate Professor David Anderson said point-of-care tests that are cheap, easy to use and...

2010-04-29 13:21:45

Limited success in modeling the behavior of the complex, unusual and unpredictable HIV virus has slowed efforts to develop an effective vaccine to prevent AIDS. A new improved modeling system, developed by Chinese researchers, which attempts to incorporate more of the virus' random behavioral dynamics, suggests that a particular type of T cell could be useful in the development of an AIDS vaccine. New research published today, Thursday 29 April, in New Journal of Physics (co-owned by the...

2010-04-27 02:01:00

MELBOURNE, Australia, April 27 /PRNewswire/ -- Scientists at Australia's Burnet Institute have developed a rapid point-of-care diagnostic test for the measurement of CD4 T-cells, a marker of the immune system for people living with HIV and AIDS. Based on the measurement of cell-associated CD4 protein in whole blood samples such as a finger prick, the kit will enable patients to receive appropriate treatment earlier without having to wait for reference laboratory test results which...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.